SARAF and breast carcinoma: As a decrease in SOCE response affects malignancy of breast cancer cells, we generated a C-terminal fragment of SARAF fused to mScarlet fluorescent protein (mScarlet-C-SARAF) (Figure 2A) and evaluated the effect of its overexpression on the SOCE response.